Geneos Wealth Management
DCTH icon

Geneos Wealth Management’s Delcath Systems DCTH Stock Holding History

Geneos Wealth Management’s Portfolio DCTH Stock Details DCTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.7K Hold
923
– – ﹤0.01% 2249
2026
Q2 		$11.6K Hold
923
– – ﹤0.01% 1970
2026
Q1 		$8.56K Hold
923
– – ﹤0.01% 2025
2025
Q4 		$9.32K Hold
923
– – ﹤0.01% 1981
2025
Q3 		$9.9K Hold
923
– – ﹤0.01% 1966
2025
Q2 		$12.6K Hold
923
– – ﹤0.01% 2227
2025
Q1 		$11.8K Hold
923
– – ﹤0.01% 2194
2024
Q4 		$11.1K Buy
+923
New +$9.7K ﹤0.01% 2008

Other funds holding DCTH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Propel Bio Management
Propel Bio Management Los Angeles, California $189M AUM 71.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geneos Wealth Management's DCTH Position: Q3 2026 in Review

Geneos Wealth Management held its Delcath Systems (DCTH) position steady in Q3 2026 at 923 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2249.

Geneos Wealth Management first reported a position in DCTH in Q4 2024 and has held it in 8 quarters since. 98 funds tracked by Wall St. Rank hold DCTH as of Q3 2026.

  • Geneos Wealth Management held 923 shares of Delcath Systems worth $14.7K as of Q3 2026.
  • Geneos Wealth Management left its Delcath Systems share count unchanged in Q3 2026.
  • Delcath Systems made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #2249 holding.
  • Geneos Wealth Management first reported a position in Delcath Systems in Q4 2024 and has held it in 8 quarters since.
  • 98 funds tracked by Wall St. Rank held Delcath Systems as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.